These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1188787)

  • 1. Proceedings: Coagulation inhibitors studied with chromogenic substrate.
    Abildgaard U; Lie M; Teien A; Odegård OR
    Thromb Diath Haemorrh; 1975 Sep; 34(1):345. PubMed ID: 1188787
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Photometric assay of antithrombin III with a chromogenic substrate.
    Vinazzer H
    Thromb Diath Haemorrh; 1975 Sep; 34(1):344-5. PubMed ID: 1188785
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Coagulation inhibitors in plasma and serum.
    Odegård OR; Abildgaard U
    Thromb Diath Haemorrh; 1975 Sep; 34(1):346. PubMed ID: 1188790
    [No Abstract]   [Full Text] [Related]  

  • 4. The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material.
    Abildgaard U; Sandset PM; Andersson TR; Odegaard OR; Rosĕn S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):274-7. PubMed ID: 2465215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Determination of plasminogen by means of a chromogenic peptide substrate.
    Friberger P; Axelsson G; Korsan-Bengtsen K
    Thromb Diath Haemorrh; 1975 Sep; 34(1):321. PubMed ID: 1188729
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-thormbin III and heparin clotting times in thrombosis and atherosclerosis.
    O'Brien JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):116-23. PubMed ID: 4454034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostasis in plasmocytomas. Preliminary observations on the inhibiting activities demonstrable in the plasma and serum protein fractions.
    Recalcati P; Besana C; Ballarino M
    Haematol Lat; 1967; 10(4):317-35. PubMed ID: 5597878
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of factor X and heparin with chromogenic substrate.
    Aiach M; Michaud A; Capron L; Fiessinger JN
    Acta Chir Scand Suppl; 1982; 509():109-13. PubMed ID: 6962612
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: A method for the quantitative determination of the antithrombin III (AT III) activity in plasma and serum using the complex formation with heparin.
    Karges HE; Heimburger N; Loechelt C
    Thromb Diath Haemorrh; 1975 Sep; 34(1):347. PubMed ID: 1188792
    [No Abstract]   [Full Text] [Related]  

  • 10. High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer.
    Lindahl AK; Sandset PM; Abildgaard U; Andersson TR; Harbitz TB
    Acta Chir Scand; 1989 Aug; 155(8):389-93. PubMed ID: 2596246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
    Undar L; Ertuğrul C; Altunbaş H; Akça S
    Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Determination of factor Xa activity by means of chromogenic substrates based on the primary structure of prothrombin.
    Aurell L; Olausson A; Claeson G
    Thromb Diath Haemorrh; 1975 Nov; 34(2):591-2. PubMed ID: 1198505
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental data on the existence and significance of an anticoagulating system in fish].
    Kudriashov BA; Kalishevskaia TM; Bazaz'ian GG; Volkov VN
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1974; 2():31-6. PubMed ID: 4824513
    [No Abstract]   [Full Text] [Related]  

  • 14. Methods for the monitoring of direct thrombin inhibitors.
    Hafner G; Roser M; Nauck M
    Semin Thromb Hemost; 2002 Oct; 28(5):425-30. PubMed ID: 12420237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of anticoagulants on the activity of trypsin-like proteinases in human blood plasma].
    Babiĭ AV; Sakharov IIu; Pokrovskiĭ SN
    Biull Eksp Biol Med; 1989 Feb; 107(2):177-9. PubMed ID: 2538168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Standardization of the laboratory method for antithrombin activity measurement].
    Okajima K
    Rinsho Byori; 2002 Mar; 50(3):283-6. PubMed ID: 11985057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the reliability of the use of heparin immobilized on agarose for the study of the interactions among heparin, thrombin and antithrombin.
    Fish WW; Björk I
    Thromb Haemost; 1982 Aug; 48(1):84-6. PubMed ID: 7135347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficiency and limits of blood coagulation tests].
    Róka L
    Internist (Berl); 1973 Apr; 14(4):149-53. PubMed ID: 4577209
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative activity of plasmin, thrombin and trypsin on chromogenic arginine-p-nitroanilides].
    Somorin O; Tokura S
    Biokhimiia; 1980 Jul; 45(7):1167-74. PubMed ID: 6260241
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis of heparin cofactor II].
    Takahashi K; Yamagishi R; Niwa M; Sakuragawa N
    Rinsho Byori; 1987 Apr; Spec No 70():181-6. PubMed ID: 3302388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.